REVIEW
Add like
Add dislike
Add to saved papers

Single-port laparoscopic appendectomy versus conventional laparoscopic appendectomy: evidence from randomized controlled trials and nonrandomized comparative studies.

BACKGROUND: Single-port laparoscopic appendectomy (SPLA) has gained widespread acceptance and is increasingly performed. The evidence assessing the safety and efficacy of SPLA compared with conventional laparoscopic appendectomy (CLA) is growing; however, very few randomized trials exist and individual studies often have small patient numbers with varying results. We integrated the available data to enhance the current literature by comparing these techniques.

METHODS: A systematic review of the literature was performed to identify studies comparing SPLA and CLA. Operative parameters, postoperative outcomes, and postoperative complications were evaluated. Meta-analysis was performed using Review Manage Version 5.0 software.

RESULTS: Fifteen studies matched the selection criteria, including 1560 patients (46.1% SPLA, 53.9% CLA). SPLA was associated with longer operative time compared with CLA procedure (P=0.001). There were no significant statistical differences between the SPLA and CLA groups in terms of postoperative outcomes including postoperative visual analog scale pain scores (P=0.12), time to return to diet (P=0.45), time to flatus (P=0.89), leukocyte count (P=0.86) and C-reactive protein level (P=0.70) evaluation after operation, cosmetic satisfaction level (P=0.95), and length of hospital stay (P=0.16). The overall complication rates were not significantly different between the 2 groups (P=0.44). There was no evidence to suggest heterogeneity of trial results.

CONCLUSIONS: SPLA shows no benefit over CLA, including even parameters such as postoperative pain and cosmetic results, and, therefore, there is no indication to use this approach over standard laparoscopic appendectomy. SPLA does take longer to perform. Further studies are needed to confirm that the procedure is more costly.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app